Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age (English, HTML)

Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age: English HTML file. From Public Health Agency of Canada, updated Nov 2021. View metadata, licence and the direct download on CanQuery.

Format
HTML
Access
Original download only
Publisher-reported update
2021-11-05

The Pfizer-BioNTech and Moderna COVID-19 vaccines are mRNA vaccines that were initially authorized by Health Canada for use in individuals 16 and 18 years of age and older, respectively, in December 2020. On May 5, 2021, Health Canada expanded the Interim Order authorization for the Pfizer-BioNTech COVID-19 vaccine to also include adolescents 12 to 15 years of age based on clinical trial results in this age group.

Access original file

Data overview

Formats
HTML
File languages
English
Available actions
Access original file

Official sources and licences

Related open data